These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24942029)

  • 1. Complications of Reduced Intensity Conditioning HSCT for XIAP Deficiency (Alloimmune Cytopenias and HLH) Successfully Managed With Donor Lymphocyte Infusion.
    Varghese AS; Lee H; Bonney D; Hughes S; Wynn R
    J Pediatr Hematol Oncol; 2015 Apr; 37(3):e198-9. PubMed ID: 24942029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful Allogeneic Hematopoietic Stem Cell Transplantation in XIAP Deficiency Using Reduced-Intensity Conditioning.
    Chellapandian D; Krueger J; Schechter T; Gassas A; Weitzman S; Naqvi A; Ali M
    Pediatr Blood Cancer; 2016 Feb; 63(2):355-7. PubMed ID: 26398727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haploidentical Hematopoietic Stem Cell Transplantation for XIAP Deficiency: a Single-Center Report.
    Yang J; Zhu GH; Wang B; Zhang R; Jia CG; Yan Y; Ma HH; Qin MQ
    J Clin Immunol; 2020 Aug; 40(6):893-900. PubMed ID: 32627096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic Stem Cell Transplantation for XIAP Deficiency in Japan.
    Ono S; Okano T; Hoshino A; Yanagimachi M; Hamamoto K; Nakazawa Y; Imamura T; Onuma M; Niizuma H; Sasahara Y; Tsujimoto H; Wada T; Kunisaki R; Takagi M; Imai K; Morio T; Kanegane H
    J Clin Immunol; 2017 Jan; 37(1):85-91. PubMed ID: 27815752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful stem cell transplant with antibody-based conditioning for XIAP deficiency with refractory hemophagocytic lymphohistiocytosis.
    Worth AJ; Nikolajeva O; Chiesa R; Rao K; Veys P; Amrolia PJ
    Blood; 2013 Jun; 121(24):4966-8. PubMed ID: 23766462
    [No Abstract]   [Full Text] [Related]  

  • 7. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
    Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fludarabine-based reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in primary hemophagocytic lymphohistiocytosis.
    Hamidieh AA; Pourpak Z; Hashemi S; Yari K; Fazlollahi MR; Movahedi M; Behfar M; Moin M; Ghavamzadeh A
    Eur J Haematol; 2014 Apr; 92(4):331-6. PubMed ID: 24330187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis.
    Marsh RA; Kim MO; Liu C; Bellman D; Hart L; Grimley M; Kumar A; Jodele S; Myers KC; Chandra S; Leemhuis T; Mehta PA; Bleesing JJ; Davies SM; Jordan MB; Filipovich AH
    Biol Blood Marrow Transplant; 2013 Nov; 19(11):1625-31. PubMed ID: 24035782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk for complications in patients with hemophagocytic lymphohistiocytosis who undergo hematopoietic stem cell transplantation: myeloablative versus reduced-intensity conditioning regimens.
    Schechter T; Naqvi A; Weitzman S
    Expert Rev Clin Immunol; 2014 Aug; 10(8):1101-6. PubMed ID: 24871821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic hematopoietic stem-cell transplantation for adult and adolescent hemophagocytic lymphohistiocytosis: a single center analysis.
    Fu L; Wang J; Wei N; Wu L; Wang Y; Huang W; Zhang J; Liu J; Wang Z
    Int J Hematol; 2016 Nov; 104(5):628-635. PubMed ID: 27431489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haploidentical hematopoietic stem cell transplantation for adult patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Li Z; Wang Y; Wang J; Zhang J; Wang Z
    Leuk Lymphoma; 2018 Jan; 59(1):77-84. PubMed ID: 28573910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced-Intensity/Reduced-Toxicity Conditioning Approaches Are Tolerated in XIAP Deficiency but Patients Fare Poorly with Acute GVHD.
    Arnold DE; Nofal R; Wakefield C; Lehmberg K; Wustrau K; Albert MH; Morris EC; Heimall JR; Bunin NJ; Kumar A; Jordan MB; Cole T; Choo S; Brettig T; Speckmann C; Ehl S; Salamonowicz M; Wahlstrom J; Rao K; Booth C; Worth A; Marsh RA
    J Clin Immunol; 2022 Jan; 42(1):36-45. PubMed ID: 34586554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for mixed chimerism in children with hemophagocytic lymphohistiocytosis after reduced toxicity conditioning.
    Wustrau K; Greil J; Sykora KW; Albert MH; Burkhardt B; Lang P; Meisel R; Wössmann W; Beier R; Schulz A; Bader P; Chada M; Kühl JS; Schlegel PG; Speckmann C; Gruhn B; Seidel M; Wawer A; Ozga AK; Janka G; Ehl S; Müller I; Lehmberg K
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28523. PubMed ID: 32618429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and Outcomes of Central Nervous System Hemophagocytic Lymphohistiocytosis Relapse after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation.
    Lounder DT; Khandelwal P; Chandra S; Jordan MB; Kumar AR; Grimley MS; Davies SM; Bleesing JJ; Marsh RA
    Biol Blood Marrow Transplant; 2017 May; 23(5):857-860. PubMed ID: 28219834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation.
    El-Cheikh J; Vazquez A; Crocchiolo R; Furst S; Calmels B; Castagna L; Lemarie C; Granata A; Ladaique P; Oudin C; Faucher C; Chabannon C; Blaise D
    Am J Hematol; 2012 Dec; 87(12):1074-8. PubMed ID: 22911907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of idiopathic colitis related to XIAP deficiency with allo-HSCT using reduced-intensity conditioning.
    Tsuma Y; Imamura T; Ichise E; Sakamoto K; Ouchi K; Osone S; Ishida H; Wada T; Hosoi H
    Pediatr Transplant; 2015 Feb; 19(1):E25-8. PubMed ID: 25412586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress of diagnosis and treatment of X-linked inhibitor of apoptosis deficiency].
    Yang X; Kanegane H; Miyawaki T
    Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):428-30. PubMed ID: 22931939
    [No Abstract]   [Full Text] [Related]  

  • 20. The Role of Hematopoietic Stem Cell Transplantation in Treatment of Hemophagocytic Lymphohistiocytosis.
    Nikiforow S
    Hematol Oncol Clin North Am; 2015 Oct; 29(5):943-59. PubMed ID: 26461153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.